In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target. (Q50882019)
Jump to navigation
Jump to search
scientific article published on 19 July 2017
Language | Label | Description | Also known as |
---|---|---|---|
English | In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target. |
scientific article published on 19 July 2017 |
Statements
In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target (English)
David E Fisher
W Nicholas Haining
David E Root
John G Doench
Robert T Manguso
Hans W Pope
Margaret D Zimmer
Flavian D Brown
Kathleen B Yates
Natalie B Collins
Kevin Bi
Martin W LaFleur
Vikram R Juneja
Sarah A Weiss
Jennifer Lo
Diana Miao
Eliezer Van Allen